These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effects of prostaglandins of the E and I type on histamine release from human adenoidal mast cells. Schmitz FJ, Eichelberg D, Schmutzler W. Agents Actions; 1986 Apr; 18(1-2):113-4. PubMed ID: 2425570 [Abstract] [Full Text] [Related]
5. The effects of metoclopramide and cloxacepride on human mast cells from adenoidal tissues. Schmutzler W, Greven T, Braam U. Agents Actions; 1989 Apr; 27(1-2):110-2. PubMed ID: 2473615 [Abstract] [Full Text] [Related]
8. Enhancement of the cAMP-induced apolipoprotein-mediated cellular lipid release by calmodulin inhibitors W7 and W5 from RAW 264 mouse macrophage cell line cells. Suzuki S, Abe-Dohmae S, Fukutomi T, Ito S, Itoh M, Yokoyama S. J Cardiovasc Pharmacol; 2000 Nov; 36(5):609-16. PubMed ID: 11065221 [Abstract] [Full Text] [Related]
9. Relation between inhibition of calmodulin and mediator release from rat mast cells. Ohishi K, Suzuki T, Uchida MK. Gen Pharmacol; 1985 Nov; 16(4):335-9. PubMed ID: 2412934 [Abstract] [Full Text] [Related]
10. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK. Clin Exp Allergy; 1992 Mar; 22(3):401-9. PubMed ID: 1375128 [Abstract] [Full Text] [Related]
13. Calmodulin antagonists stimulate renin release from isolated rat glomeruli. Kawamura M, Inagami T. Endocrinology; 1983 May; 112(5):1857-9. PubMed ID: 6187563 [Abstract] [Full Text] [Related]
14. Comparison of histamine release from human blood monocytes, lymphocytes, adenoidal and skin mast cells. Schmutzler W, Bolsmann K, Zwadlo-Klarwasser G. Int Arch Allergy Immunol; 1995 May; 107(1-3):194-6. PubMed ID: 7542070 [Abstract] [Full Text] [Related]
15. Effect of calmodulin inhibitors on histamine secretion from mast cells. Peachell PT, Pearce FL. Agents Actions; 1985 Mar; 16(1-2):43-4. PubMed ID: 2408448 [Abstract] [Full Text] [Related]
16. [Mast cells of the pharyngeal tonsils]. Brzezińska-Błaszczyk E, Brzezińska H. Otolaryngol Pol; 1989 Mar; 43(1):29-34. PubMed ID: 2478943 [Abstract] [Full Text] [Related]
17. The role of a Ca2+/calmodulin dependent plasma membrane Ca2+ channel during concanavalin A activation of MC9 mast cells. Gulbenkian A, Myers J, Egan RW, Siegel MI. Agents Actions; 1987 Oct; 22(1-2):16-23. PubMed ID: 2446480 [Abstract] [Full Text] [Related]
18. Inhibitory mechanism of tritoqualine on histamine release from mast cells. Umezu K, Yuasa S, Ichikawa A. Biochem Pharmacol; 1986 Sep 15; 35(18):3137-42. PubMed ID: 2428378 [Abstract] [Full Text] [Related]
19. The effect of calmodulin on histamine release in the rat peritoneal mast cell. McClain DE, Donlon MA, Chock S, Catravas GN. Biochim Biophys Acta; 1983 Dec 19; 763(4):419-25. PubMed ID: 6197097 [Abstract] [Full Text] [Related]
20. CGS 9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells. Safayhi H, Kühn M, Koopmann I, Ammon HP. Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec 19; 339(1-2):8-13. PubMed ID: 2657441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]